Peapack Gladstone Financial Corp Increases Stock Holdings in Haleon plc (NYSE:HLN)

Peapack Gladstone Financial Corp lifted its stake in shares of Haleon plc (NYSE:HLN) by 3.2% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 44,844 shares of the company’s stock after acquiring an additional 1,390 shares during the period. Peapack Gladstone Financial Corp’s holdings in Haleon were worth $474,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Fortitude Family Office LLC purchased a new stake in shares of Haleon during the 3rd quarter valued at about $28,000. Toronto Dominion Bank raised its holdings in shares of Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after buying an additional 3,470 shares during the period. Cultivar Capital Inc. purchased a new stake in shares of Haleon during the 2nd quarter valued at about $40,000. Prospera Private Wealth LLC acquired a new stake in Haleon during the 3rd quarter valued at approximately $57,000. Finally, BOKF NA grew its stake in Haleon by 68.8% during the 2nd quarter. BOKF NA now owns 6,972 shares of the company’s stock valued at $58,000 after purchasing an additional 2,842 shares in the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HLN has been the subject of a number of recent analyst reports. Morgan Stanley raised their price objective on Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research note on Friday, September 20th. UBS Group upgraded Haleon to a “strong-buy” rating in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Haleon presently has a consensus rating of “Buy” and a consensus target price of $10.95.

Haleon Price Performance

Shares of NYSE HLN opened at $9.76 on Monday. The firm has a market cap of $44.18 billion, a PE ratio of 28.71, a price-to-earnings-growth ratio of 2.95 and a beta of 0.28. The business has a 50 day moving average price of $9.75 and a two-hundred day moving average price of $9.53. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.